Syndax Pharmaceuticals (SNDX) Non-cash Items (2015 - 2025)

Syndax Pharmaceuticals' Non-cash Items history runs 11 years deep, the most recent figure standing at $7.5 million for Q4 2025.

• In Q4 2025, Non-cash Items fell 22.78% year-over-year to $7.5 million; the TTM figure through Dec 2025 stood at $7.5 million (down 22.78% YoY), while the FY2025 annual figure was $7.5 million, up 13.13% from the prior year.
• Non-cash Items was $7.5 million for Q4 2025 at Syndax Pharmaceuticals, down from $9.7 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $88.0 million in Q4 2022 to a low of $83000.0 in Q1 2022.
• Historically, Non-cash Items has averaged $35.2 million across 5 years, with a median of $20.7 million in 2021.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items slumped 99.74% in 2022, then surged 93634.94% in 2023.
• A 5-year view of Non-cash Items shows it stood at $68.6 million in 2021, then gained by 28.29% to $88.0 million in 2022, then slumped by 37.41% to $55.1 million in 2023, then tumbled by 82.31% to $9.7 million in 2024, then declined by 22.78% to $7.5 million in 2025.
• The last three Non-cash Items figures came in at $7.5 million (Q4 2025), $9.7 million (Q4 2024), and $55.1 million (Q4 2023), per Business Quant data.